4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-040143
Chief Medical Officer sold 2,000 shares at an average $58.74 ($117,480)
- Chief Medical Officer acquired 2,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garren Hideki Chief Medical Officer | 2023-08-16 | Option exercise 10b5-1 | +2,000 | $24.90 | $49,800 | 2,000 | D |
| Garren Hideki Chief Medical Officer | 2023-08-16 | Sale 10b5-1 | −878 | $58.15 | $51,059 | 1,122 | D |
| Garren Hideki Chief Medical Officer | 2023-08-16 | Sale 10b5-1 | −748 | $58.93 | $44,079 | 374 | D |
| Garren Hideki Chief Medical Officer | 2023-08-16 | Sale 10b5-1 | −374 | $59.74 | $22,341 | 0 | D |
| Derivatives | |||||||
| Garren Hideki Chief Medical Officer | 2023-08-16 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 194,000 | D | ||
| Open-market sales · 2,000 sh · avg $58.74 · $117,480 | |||||||
Loading xslF345X05/form4.xml…